1.
MEDLINE; 2020.
Non-conventional
in English
| MEDLINE | ID: grc-750619
2.
Clin J Am Soc Nephrol
; 15(10): 1494-1495, 2020 10 07.
Article
in English
| MEDLINE | ID: covidwho-688671
Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/virology , Immunocompromised Host , Immunosuppressive Agents/adverse effects , Nephrotic Syndrome/drug therapy , Opportunistic Infections/virology , Pneumonia, Viral/virology , Rituximab/adverse effects , Adolescent , Adult , Betacoronavirus/immunology , COVID-19 , Coronavirus Infections/immunology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Female , Humans , Male , Nephrotic Syndrome/diagnosis , Nephrotic Syndrome/immunology , Opportunistic Infections/immunology , Opportunistic Infections/prevention & control , Opportunistic Infections/transmission , Pandemics/prevention & control , Pneumonia, Viral/immunology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Prospective Studies , Randomized Controlled Trials as Topic , Recurrence , Risk Assessment , Risk Factors , SARS-CoV-2 , Time Factors , Treatment Outcome , Young Adult
3.
Clin Transplant
; 34(7): e13889, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-245796